US Patent Issued to NanoVision Therapeutics on Sept. 29 for "DNA vector delivery using lipid nanoparticles" (Canadian, German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,293, issued on Sept. 29, was assigned to NanoVision Therapeutics Inc. (Vancouver, Canada).

"DNA vector delivery using lipid nanoparticles" was invented by Jayesh Kulkarni (Vancouver, Canada), Daniel Kurek (Vancouver, Canada), Anthony C. Y. Tam (Vancouver, Canada), Kate E. R. Hollinshead (Vancouver, Canada) and Dominik Witzigmann (Binzen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a lipid nanoparticle comprising encapsulated DNA vector and 30 to 60 mol % of a neutral lipid selected from sphingomyelin and a phosphatidylcholine lipid, and at least one of a sterol and a hydrophilic polymer-lipid conjugate, th...